NDC 71671-100

Twirla

Levonorgestrel/ethinyl Estradiol

Twirla is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Agile Therapeutics, Inc.. The primary component is Levonorgestrel; Ethinyl Estradiol.

Product ID71671-100_45f57fff-9cb9-4113-b178-c0868bcac5d8
NDC71671-100
Product TypeHuman Prescription Drug
Proprietary NameTwirla
Generic NameLevonorgestrel/ethinyl Estradiol
Dosage FormPatch
Route of AdministrationTRANSDERMAL
Marketing Start Date2020-09-11
Marketing CategoryNDA /
Application NumberNDA204017
Labeler NameAgile Therapeutics, Inc.
Substance NameLEVONORGESTREL; ETHINYL ESTRADIOL
Active Ingredient Strength3 mg/1; mg/1
Pharm ClassesInhibit Ovum Fertilization [PE],Progesterone Congeners [CS],Progesterone Congeners [CS],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen Receptor Agonists [MoA],Estrogen [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71671-100-01

1 POUCH in 1 CARTON (71671-100-01) > 1 PATCH in 1 POUCH (71671-100-11)
Marketing Start Date2020-09-11
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.